The Registry of Toxic Effects of Chemical Substances
Phenol, p - chloro - |
UPDATE: February 2004 | MW: 128.56 | MF: C6H5ClO |
SYNONYMS:
|
|
|
SKIN AND EYE IRRITATION DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
eye | rabbit
250 µg/24 hour
|
severe
|
85JCAE -,523,1986
|
skin | rabbit
2 mg/24 hour
|
severe
|
85JCAE -,523,1986
|
|
MUTATION DATA AND REFERENCES:
SYSTEM TEST
|
ROUTE/ | ORGANISM/ TISSUE
DOSE
|
REFERENCE
|
cytogenetic analysis
|
oral | rat
81 mg/kg
|
ZKMAAX 25,339,1985
|
mutation in microorganisms
|
Salmonella typhimurium
|
200 µg/plate (+enzymatic activation step)
|
PCBPBS 10,174,1979
|
mutation in microorganisms
|
Salmonella typhimurium
|
10 µg/plate (-enzymatic activation step)
|
TECSDY 14,143,1987
|
|
REPRODUCTIVE EFFECTS DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | mouse
lowest published toxic concentration: 760 µg/m3/24 hour (17 week male)
|
Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) | Reproductive: Effects on fertility: Post- implantation mortality (e.g., dead and/or resorbed implants per total number of implants) Reproductive: Effects on embryo or fetus: Fetal death
GISAAA 57(7-8),9,1992
|
oral | rat
lowest published toxic dose: 3,500 mg/kg (70 day prior to copulation)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
VCVGK* -,244,1994
|
oral | rat
lowest published toxic dose: 550 mg/kg (1-22 day pregnant)
|
Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus)
|
VCVGK* -,244,1994
|
|
TUMORIGENIC DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
N/R |
N/R
|
N/R
|
N/R
|
|
ACUTE TOXICITY DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | human
lowest published toxic concentration: 10 gm/m3/8 hour
|
Behavioral: Excitement | Behavioral: Irritability Nutritional and Gross Metabolic: Other changes
GISAAA 29(10),37,1964
|
inhalation | mouse
lowest published lethal concentration: 3,200 mg/m3/2 hour
|
Brain and Coverings: Other degenerative changes | Lung, Thorax, or Respiration: Other changes Liver: Other changes
GISAAA 57(7-8),9,1992
|
inhalation | rat
lethal concentration (50 percent kill): 11 mg/m3
|
N/R
|
GISAAA 29(10),37,1964
|
intraperitoneal | mouse
lethal dose (50 percent kill): 332 mg/kg
|
N/R
|
JMCMAR 18,868,1975
|
intraperitoneal | rat
lethal dose (50 percent kill): 281 mg/kg
|
Behavioral: Tremor | Behavioral: Convulsions or effect on seizure threshold Nutritional and Gross Metabolic: Body temperature increase
BJPCAL 13,20,1958
|
intraperitoneal | rat
lethal dose (50 percent kill): 281 mg/kg
|
Brain and Coverings: Other degenerative changes | Liver: Other changes Kidney, Ureter, and Bladder: Other changes
VCVGK* -,245,1994
|
oral | mammal (species unspecified)
lethal dose (50 percent kill): 500 mg/kg
|
N/R
|
GISAAA 45(10),16,1980
|
oral | mouse
lethal dose (50 percent kill): 367 mg/kg
|
Behavioral: Excitement | Behavioral: Coma
ZKMAAX 25,339,1985
|
oral | mouse
lethal dose (50 percent kill): 1,373 mg/kg
|
Behavioral: Tremor | Behavioral: Convulsions or effect on seizure threshold
TOLED5 29,39,1985
|
oral | mouse
lethal dose (50 percent kill): 605 mg/kg
|
Brain and Coverings: Other degenerative changes | Liver: Other changes Kidney, Ureter, and Bladder: Other changes
VCVGK* -,245,1994
|
oral | rat
lethal dose (50 percent kill): 670 mg/kg
|
N/R
|
FEPRA7 2,76,1943
|
oral | rat
lethal dose (50 percent kill): 261 mg/kg
|
Brain and Coverings: Other degenerative changes | Liver: Other changes Kidney, Ureter, and Bladder: Other changes
VCVGK* -,245,1994
|
subcutaneous | rat
lethal dose (50 percent kill): 1,030 mg/kg
|
N/R
|
FEPRA7 2,76,1943
|
subcutaneous | rat
lethal dose (50 percent kill): 1,030 mg/kg
|
Brain and Coverings: Other degenerative changes | Liver: Other changes Kidney, Ureter, and Bladder: Other changes
VCVGK* -,245,1994
|
skin | mammal (species unspecified)
lethal dose (50 percent kill): 1 gm/kg
|
N/R
|
GISAAA 45(10),16,1980
|
skin | rat
lethal dose (50 percent kill): 1,500 mg/kg
|
Behavioral: Muscle contraction or spasticity | Skin: After topical application: Corrosive
GISAAA 29(10),37,1964
|
skin | rat
lethal dose (50 percent kill): 1,000 mg/kg
|
Brain and Coverings: Other degenerative changes | Liver: Other changes Kidney, Ureter, and Bladder: Other changes
VCVGK* -,245,1994
|
unreported route | mouse
lethal dose (50 percent kill): 605 mg/kg
|
Autonomic Nervous System: Other (direct) parasympathomimetic | Behavioral: Convulsions or effect on seizure threshold Behavioral: Excitement
GISAAA 54(1),68,1989
|
unreported route | rat
lethal dose (50 percent kill): 625 mg/kg
|
Autonomic Nervous System: Other (direct) parasympathomimetic | Behavioral: Convulsions or effect on seizure threshold Behavioral: Excitement
GISAAA 54(1),68,1989
|
|
OTHER MULTIPLE DOSE DATA AND REFERENCES:
ROUTE/ | ORGANISM
DOSE
|
| EFFECT
REFERENCE
|
inhalation | mouse
lowest published toxic concentration: 24 µg/m3/24 hour/17 week- intermittent
|
Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: True cholinesterase Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases
GISAAA 57(7-8),9,1992
|
inhalation | rat
lowest published toxic concentration: 2 mg/m3/6 hour/17 week- intermittent
|
Nutritional and Gross Metabolic: Other changes
|
GISAAA 29(10),37,1964
|
oral | mammal (species unspecified)
lowest published toxic dose: 182 mg/kg/26 week- intermittent
|
Liver: Other changes | Kidney, Ureter, and Bladder: Other changes
VCVGK* -,244,1994
|
|
REVIEWS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
N/R
|
N/R
|
N/R
|
|
STANDARDS AND REGULATIONS:
ORGANIZATION
|
STANDARD
|
|
REFERENCE
Occupational Exposure Limit - DENMARK
|
time-weighted average 0.5 mg/m3, Skin, JAN1999
|
Occupational Exposure Limit - POLAND
|
MAC(time-weighted average) 1 mg/m3, short term exposure limit 3 mg/m3, JAN1999
|
Occupational Exposure Limit - RUSSIA
|
short term exposure limit 1 mg/m3, Skin, JAN1993
|
Occupational Exposure Limit - SWEDEN
|
time-weighted average 0.5 mg/m3, short term exposure limit 1.5 mg/m3, Skin, JAN1999
|
|
NIOSH DOCUMENTATION AND SURVEILLANCE:
ORGANIZATION
|
STANDARD or SURVEY
|
|
REFERENCE
National Occupational Hazard Survey 1974
|
National Occupational Hazard Survey 1974: Hazard Code: 84588; | Number of Industries 4; Total Number of Facilities 185; Number of Occupations 19; Total Number of Employees Exposed 4,844
National Occupational Exposure Survey 1983
|
National Occupational Exposure Survey 1983: Hazard Code: 84588; |
Number of Industries 6; Total Number of Facilities 200; Number of Occupations 5; Total Number of Employees Exposed 2,796; Total Number of Female Employees Exposed 1,865 |
STATUS IN FEDERAL AGENCIES:
ORGANIZATION
|
|
REFERENCE
EPA TSCA Section 8(b) CHEMICAL INVENTORY
|
Used as an intermediate, a selective solvent and a denaturant
|
EPA TSCA Section 8(d) unpublished health/safety studies
|
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001
|
NIOSH Analytical Method, 1994: o-Chlorophenol, 2014
|
|
REFERENCES:
CODEN
|
|
REFERENCE
85JCAE
|
"Prehled Prumyslove Toxikologie; Organicke Latky," Marhold, J., Prague, Czechoslovakia,
Avicenum, 1986
|
BJPCAL
|
British Journal of Pharmacology and Chemotherapy. (London, UK) V.1-33, 1946-68. For
publisher information, see BJPCBM.
|
FEPRA7
|
Federation Proceedings, Federation of American Societies for Experimental Biology. (Bethesda,
MD) V.1-46, 1942-87.
|
GISAAA
|
Gigiena i Sanitariya. For English translation, see HYSAAV. (V/O Mezhdunarodnaya Kniga,
113095 Moscow, USSR) V.1- 1936-
|
JMCMAR
|
Journal of Medicinal Chemistry. (American Chemical Soc., Distribution Office Dept. 223, POB
POB 57136, West End Stn., Washington, DC 20037) V.6- 1963-
|
PCBPBS
|
Pesticide Biochemistry and Physiology. (Academic Press, Inc., 1 E. First St., Duluth, MN
55802) V.1- 1971-
|
TECSDY
|
Toxicological and Environmental Chemistry. (Gordon & Breach Science Pub. Inc., 1 Park Ave.,
New York, NY 10016) V.3(3/4)- 1981-
|
TOLED5
|
Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands)
V.1- 1977-
|
VCVGK*
|
"Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia".
(Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia,
1994.
|
ZKMAAX
|
Zhurnal Eksperimental'noi i Klinicheskoi Meditsiny. Journal of Experimental and Clinical
Medicine. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR) V.2- 1962-
|
|